Last reviewed · How we verify

Propoxyphene Compound 65 — Competitive Intelligence Brief

Propoxyphene Compound 65 (PROPOXYPHENE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Opioid Agonist. Area: Pain.

marketed Opioid Agonist Glutamate receptor ionotropic, NMDA 3A Pain Small molecule Live · refreshed every 30 min

Target snapshot

Propoxyphene Compound 65 (PROPOXYPHENE).

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Propoxyphene Compound 65 TARGET PROPOXYPHENE marketed Opioid Agonist Glutamate receptor ionotropic, NMDA 3A 1957-01-01
Cliradon KETOBEMIDONE marketed ketobemidone Delta-type opioid receptor, Glutamate receptor ionotropic, NMDA 3A, Kappa-type opioid receptor
Pethidin Pethidin Ain Shams University marketed Solute carrier family 22 member 1, Glutamate receptor ionotropic, NMDA 3A, Kappa-type opioid receptor
BENZHYDROCODONE BENZHYDROCODONE marketed Opioid analgesic combination; full mu-opioid agonist with non-opioid analgesic Mu-opioid receptors (primary); delta and kappa opioid receptors (secondary); central nervous system pain pathways 2018-01-01
Nucynta TAPENTADOL Collegium Pharm Inc marketed Opioid Agonist Mu-type opioid receptor 2008-01-01
Alfenta ALFENTANIL Rising marketed Opioid Agonist Mu-type opioid receptor 1986-01-01
Dilaudid-Hp HYDROMORPHONE Fresenius Kabi marketed Opioid Agonist mu-opioid receptor 1984-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Opioid Agonist class)

  1. · 4 drugs in this class
  2. Rising · 2 drugs in this class
  3. Pfizer · 2 drugs in this class
  4. Endo · 1 drug in this class
  5. Fresenius Kabi · 1 drug in this class
  6. Specgx Llc · 1 drug in this class
  7. Teva · 1 drug in this class
  8. Bausch Health · 1 drug in this class
  9. Collegium Pharm Inc · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Propoxyphene Compound 65 — Competitive Intelligence Brief. https://druglandscape.com/ci/propoxyphene. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: